Inactive

The Naval Medical Logistics Command (NMLC) intends to negotiate on a sole source basis (FAR 13.106-1(b)(1)), soliciting from a single source. The proposed source is Egg Medical, Inc. of 7351 Kirkwood ... The Naval Medical Logistics Command (NMLC) intends to negotiate on a sole source basis (FAR 13.106-1(b)(1)), soliciting from a single source. The proposed source is Egg Medical, Inc. of 7351 Kirkwood Ln N, Suite 121, Maple Grove, MN 55369. The x-ray shield barrier units shall minimize radiation exposure in the Catheterization Laboratory (Cath Lab) and provide passive protection for the Cath Lab staff and patients, without disruption of workflow. The x-ray shields shall be capable of providing at least 90% reduction in scatter radiation. The x-ray shields shall be utilized for reduction in scatter radiation during various procedures, which include but are not limited to the following: transesophageal echocardiograms, pacemaker/implantable cardioverter-defibrillator (ICD) implants, cardiac ablations, and interventional cardiology. The x-ray shields shall drape over the existing Cath Lab operatory, radiolucent tables and articulate with the table and with the c-arm. Due to on-bed positioning and draping over the 132 in. by 26 in. (11 ft.by 2 ft., 1/6 in.) Cath Lab table around the c-arm, the x-ray shields shall assist in reducing scatter radiation exposure to the entire Cath Lab staff, regardless of where the staff personnel are standing in the room. The x-ray shields shall provide effective shielding above and below the Cath Lab table, without interfering with c-arm movement. Each unit shall include a memory foam mattress to provide extra support for more effective cardiopulmonary resuscitation (CPR). Each x-ray shield shall be attached to a Cath Lab during procedures, but shall be capable of being detached. In addition, each x-ray shield unit shall be designed with the following characteristics: • Radiolucent hard surface platform, to be placed on the Cath Lab table to provide more support during procedures • Integrated rails designed to move with the patient with ease • Mattress that provides chest support, and allows for stand chest compressions during CPR • Integrated Trendelenburg system feature to assist patient • Antimicrobial capabilities, with easy-to-clean surfaces The vendor shall include two (2) operator manuals and two (2) service manuals. Vendor shall be an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor, or authorized reseller for the proposed equipment/system, such that OEM warranty and service are provided and maintained by the OEM. All software licensing, warranty, and service associated with the equipment/system shall be in accordance with the OEM terms and conditions. The system, including claims made for the product, shall be compliant with Food and Drug Administration (FDA) regulations, with respect to marketing and delivering medical products for use in the United States of America. These requirements shall apply even if delivery is requested outside of the United States of America. The system shall be installed in compliance with OSHA requirements. Upon delivery, the contractor shall be responsible for uncrating each unit/system, transporting it through the facility to the location of intended use for installation, and removing of all trash created in this process. If interim storage is required, the vendor shall make arrangements for the storage. The vendor is also responsible for conducting operational and performance tests with the x-ray system at NMCSD and each x-ray shield unit. There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 339112. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Submit email capability statements (using PDF, MS Word, Excel attachments) to Kerry McKean at kerry.a.mckean.civ@mail.mil. Statements are due no later than 1300 ET 10 April 2019. No phone calls will be accepted.